推荐产品
方案
>99% (TLC)
表单
powder
包装
pkg of 1 × 1 mg (857341P-1mg)
制造商/商品名称
Avanti Research™ - A Croda Brand 857341P
脂质类型
phospholipids
cardiolipins
运输
dry ice
储存温度
−20°C
SMILES字符串
O=C(CCCCCCC/C=C\CCCCCCCC)N[C@H](COP(O)([O-])=O)CC1=CC=C(OCC2=CC=CC=C2)C=C1.[NH4+]
一般描述
VPC 12249 is an N-acyl (oleoyl) serine phosphate-based compound.
应用
VPC 12249 has been used as lysophosphatidic acid (LPA)1/3 receptor antagonist in various experimental studies.
生化/生理作用
Lysophosphatidic acids (LPAs) are bioactive lipid mediators. It interacts with at least six specific LPA receptors (LPA1-6) to mediate extracellular signaling pathway. LPA and its receptors (LPA1-3) are implicated in the pathogenesis of radiation pneumonitis (RP). VPC 12249 (S) inhibits the binding ofLPA to LPA1 and LPA3 receptor.
包装
5 mL Amber Glass Screw Cap Vial (857341P-1mg)
法律信息
Avanti Research is a trademark of Avanti Polar Lipids, LLC
储存分类代码
13 - Non Combustible Solids
WGK
WGK 3
法规信息
新产品
Possible role of lysophosphatidic acid in rat model of hypoxic pulmonary vascular remodeling
Pulmonary Circulation, 4(3), 471-481 (2014)
LPA receptor signaling: pharmacology, physiology, and pathophysiology
Journal of Lipid Research, 55(7), 1192-1214 (2014)
Identification of a phosphothionate analogue of lysophosphatidic acid (LPA) as a selective agonist of the LPA3 receptor
The Journal of Biological Chemistry, 278(14), 11962-11969 (2003)
Effects of lysophosphatidic acid and its receptors LPA 1/3; on radiation pneumonitis
Oncology Reports, 24(6), 1515-1520 (2010)
Lysophosphatidic acid inhibits insulin signaling in primary rat hepatocytes via the LPA3 receptor subtype and is increased in obesity
Cellular Physiology and Biochemistry, 43(2), 445-456 (2017)
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门